Indication
GNR-084
1 clinical trial
3 products
Clinical trial
Dose-escalation Sequention Cohort Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GNR-084 in Patients With Refractory or Relapse Acute Lymphoblastic B-cell Precursor Leukemia.Status: Recruiting, Estimated PCD: 2025-02-01
Product
Cohort 3, GNR-084Product
GNR-084Product
Cohort 1, GNR-084